Granza Bio
YC W24San Francisco, US · Founded 2024 · 7 employees · 3 known investors
Granza Bio develops immunotherapy treatments leveraging naturally-occurring attack particles that are released from cytotoxic immune cells to target diseases including cancers, autoimmunity, and infections.
BiotechDeep TechDigital HealthHealthtechSynthetic BiologyHealthcareTherapeuticsOncologyin /101140973/@GranzaBio
Founders & leadership· Y Combinator alumni (W24)
Investors · 3
In the news
- Granza Bio Raises $7M+ Seed Funding to Advance the Delivery of Cancer Treatment and Genetic Medicinesprnewswire.com · 2024
- US-based Granza Bio raises $7M to advance cancer treatment delivery — TFNtechfundingnews.com · 2024
- Granza Bio Raises $7M+ in Seed Fundingfinsmes.com · 2024
- Granza Bio Secures $7M to Revolutionize Cancer Treatment Deliverytechnews180.com · 2024
- Granza Bio grabs $7M seed from Felicis and YC to advance delivery of cancer treatments | TechCrunchtechcrunch.com · 2024
- Granza Bio - 2026 Company Profile, Team, Funding & Competitors - Tracxntracxn.com · 2024
- Granza Bio - 2026 Funding Rounds & List of Investors - Tracxntracxn.com · 2024